Literature DB >> 20666704

HLA class I and class II polymorphisms in Tunisian Berbers.

A Hajjej1, M H Sellami, H Kaabi, G Hajjej, A El-Gaaied, K Boukef, W Y Almawi, S Hmida.   

Abstract

BACKGROUND: The HLA polymorphism is a powerful genetic tool to study population origins. By analysing allele frequencies and haplotypes in different populations, it is possible to identify ethnic groups and establish the genetic relationships among them. AIM: The Berber (endogenous Tunisians) HLA class I and class II genotypes were analysed and compared with those of Mediterranean and Sub-Saharan African communities using genetic distances, Neighbour-Joining dendrograms, correspondence and haplotype analysis. SUBJECTS AND METHODS: One hundred and five unrelated Berbers were typed for HLA class I (A, B) and class II (DRB1, DQB1) gene alleles using reverse dot-blot hybridization.
RESULTS: High frequencies of A*0201 (24.76%), A*3402 (22.38%) and B*44 (32.85%) alleles were recorded for Berbers, the highest recorded for Mediterranean and North African populations. This study shows a close relatedness of Tunisian Berbers to other Tunisians, North Africans and Iberians.
CONCLUSION: The apparent relatedness of Tunisian Berbers to present-day (North African) Tunisians, Algerians and Moroccans suggests that the Arab invasion of North Africa (7(th)-11(th) centuries AD) did not significantly impact the genetic makeup of North Africans. Furthermore, Tunisian Berbers appear to be closely related to Iberians (Spaniards and Basques), indicating that the 7(th) century AD gene flow of invaders was low in Iberians and that the main part of their genetic pool came after the Northward Saharan migration, when hyper-arid conditions were established in Sahara (before 6000 BC). Other studied populations belong to the old Mediterranean substratum, which has been present in the area since pre-Neolithic times. This study indicates a higher proportion of Iberian than Arab ancestry in Tunisian Berbers, which is of value in evaluating the evolutionary history of present-day Tunisians. Greeks seem to share genetic HLA features (Chr 6) with Sub-Saharans. The relatedness of Greeks to Sub-Saharans has been confirmed by other studies based on chromosome 7 genetic markers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20666704     DOI: 10.3109/03014460.2010.504195

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  6 in total

1.  HLA in Georgians (Caucasus) and their relationship with Eastern Mediterraneans.

Authors:  Diego Rey; Cristina Areces; Javier Alonso-Rubio; Mercedes Enríquez-de-Salamanca; Sedeka Abd-El-Fatah-Khalil; Nina Bendikuze; Mercedes Fernández-Honrado; Luz Barbolla; José Manuel Martín-Villa; Antonio Arnaiz-Villena
Journal:  Mol Biol Rep       Date:  2013-10       Impact factor: 2.316

2.  The investigation of the origin of Southern Tunisians using HLA genes.

Authors:  Abdelhafidh Hajjej; Wassim Y Almawi; Lasmar Hattab; Amel El-Gaaied; Slama Hmida
Journal:  J Hum Genet       Date:  2016-11-24       Impact factor: 3.172

3.  HLA Class I and Class II Alleles and Haplotypes Confirm the Berber Origin of the Present Day Tunisian Population.

Authors:  Abdelhafidh Hajjej; Wassim Y Almawi; Lasmar Hattab; Amel El-Gaaied; Slama Hmida
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

4.  The genetic heterogeneity of Arab populations as inferred from HLA genes.

Authors:  Abdelhafidh Hajjej; Wassim Y Almawi; Antonio Arnaiz-Villena; Lasmar Hattab; Slama Hmida
Journal:  PLoS One       Date:  2018-03-09       Impact factor: 3.240

5.  Genetics and genomic medicine in Tunisia.

Authors:  Houda Elloumi-Zghal; Habiba Chaabouni Bouhamed
Journal:  Mol Genet Genomic Med       Date:  2018-03       Impact factor: 2.183

6.  Distribution of HLA-B Alleles and Haplotypes in Qatari: Recommendation for Establishing Pharmacogenomic Markers Screening for Drug Hypersensitivity.

Authors:  Mohammed Dashti; Abdullah Al-Matrouk; Arshad Channanath; Prashantha Hebbar; Fahd Al-Mulla; Thangavel Alphonse Thanaraj
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.